Logo image of AEYE

AUDIOEYE INC (AEYE) Stock Fundamental Analysis

NASDAQ:AEYE - Nasdaq - US0507342014 - Common Stock - Currency: USD

12.15  -0.35 (-2.8%)

After market: 12.15 0 (0%)

Fundamental Rating

3

Overall AEYE gets a fundamental rating of 3 out of 10. We evaluated AEYE against 283 industry peers in the Software industry. Both the profitability and financial health of AEYE have multiple concerns. While showing a medium growth rate, AEYE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AEYE had negative earnings in the past year.
AEYE had a positive operating cash flow in the past year.
In the past 5 years AEYE always reported negative net income.
In multiple years AEYE reported negative operating cash flow during the last 5 years.
AEYE Yearly Net Income VS EBIT VS OCF VS FCFAEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

With a Return On Assets value of -14.29%, AEYE is not doing good in the industry: 64.66% of the companies in the same industry are doing better.
With a Return On Equity value of -45.08%, AEYE is not doing good in the industry: 66.78% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.29%
ROE -45.08%
ROIC N/A
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
AEYE Yearly ROA, ROE, ROICAEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

1.3 Margins

With a decent Gross Margin value of 79.37%, AEYE is doing good in the industry, outperforming 79.15% of the companies in the same industry.
In the last couple of years the Gross Margin of AEYE has grown nicely.
AEYE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
AEYE Yearly Profit, Operating, Gross MarginsAEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

2

2. Health

2.1 Basic Checks

AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AEYE has been increased compared to 1 year ago.
The number of shares outstanding for AEYE has been increased compared to 5 years ago.
AEYE has a better debt/assets ratio than last year.
AEYE Yearly Shares OutstandingAEYE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
AEYE Yearly Total Debt VS Total AssetsAEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 0.98, we must say that AEYE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.98, AEYE is not doing good in the industry: 62.19% of the companies in the same industry are doing better.
The Debt to FCF ratio of AEYE is 8.63, which is on the high side as it means it would take AEYE, 8.63 years of fcf income to pay off all of its debts.
AEYE has a Debt to FCF ratio (8.63) which is in line with its industry peers.
A Debt/Equity ratio of 0.72 indicates that AEYE is somewhat dependend on debt financing.
The Debt to Equity ratio of AEYE (0.72) is worse than 70.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 8.63
Altman-Z 0.98
ROIC/WACCN/A
WACC11.35%
AEYE Yearly LT Debt VS Equity VS FCFAEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

AEYE has a Current Ratio of 1.05. This is a normal value and indicates that AEYE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.05, AEYE is not doing good in the industry: 73.50% of the companies in the same industry are doing better.
AEYE has a Quick Ratio of 1.05. This is a normal value and indicates that AEYE is financially healthy and should not expect problems in meeting its short term obligations.
AEYE has a Quick ratio of 1.05. This is in the lower half of the industry: AEYE underperforms 72.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
AEYE Yearly Current Assets VS Current LiabilitesAEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.69% over the past year.
The Revenue has grown by 12.41% in the past year. This is quite good.
The Revenue has been growing by 26.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)12.41%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%20.41%

3.2 Future

Based on estimates for the next years, AEYE will show a very strong growth in Earnings Per Share. The EPS will grow by 60.71% on average per year.
The Revenue is expected to grow by 18.26% on average over the next years. This is quite good.
EPS Next Y63.86%
EPS Next 2Y60.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.79%
Revenue Next 2Y18.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AEYE Yearly Revenue VS EstimatesAEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
AEYE Yearly EPS VS EstimatesAEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

AEYE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AEYE is valuated quite expensively with a Price/Forward Earnings ratio of 59.56.
AEYE's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of AEYE to the average of the S&P500 Index (21.76), we can say AEYE is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 59.56
AEYE Price Earnings VS Forward Price EarningsAEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of AEYE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 191.48
EV/EBITDA N/A
AEYE Per share dataAEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AEYE's earnings are expected to grow with 60.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.71%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AEYE!.
Industry RankSector Rank
Dividend Yield N/A

AUDIOEYE INC

NASDAQ:AEYE (5/23/2025, 9:12:03 PM)

After market: 12.15 0 (0%)

12.15

-0.35 (-2.8%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-23 2025-07-23
Inst Owners39.55%
Inst Owner Change5.72%
Ins Owners32.45%
Ins Owner Change8.25%
Market Cap151.27M
Analysts81.82
Price Target22.85 (88.07%)
Short Float %6.46%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)-1.38%
Revenue beat(8)0
Avg Revenue beat(8)-1.89%
Revenue beat(12)0
Avg Revenue beat(12)-1.76%
Revenue beat(16)0
Avg Revenue beat(16)-1.8%
PT rev (1m)-15.15%
PT rev (3m)-31.5%
EPS NQ rev (1m)-250%
EPS NQ rev (3m)80%
EPS NY rev (1m)-181.58%
EPS NY rev (3m)-338.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-2.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 59.56
P/S 4.3
P/FCF 191.48
P/OCF 55.39
P/B 16.03
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)0.2
Fwd EY1.68%
FCF(TTM)0.06
FCFY0.52%
OCF(TTM)0.22
OCFY1.81%
SpS2.83
BVpS0.76
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.29%
ROE -45.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.37%
FCFM 2.24%
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
F-Score5
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 8.63
Debt/EBITDA N/A
Cap/Depr 76.75%
Cap/Sales 5.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 0.98
F-Score5
WACC11.35%
ROIC/WACCN/A
Cap/Depr(3y)77.02%
Cap/Depr(5y)97.08%
Cap/Sales(3y)5.53%
Cap/Sales(5y)5.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y63.86%
EPS Next 2Y60.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.41%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%20.41%
Revenue Next Year17.79%
Revenue Next 2Y18.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year645.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y142.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y758.81%
OCF growth 3YN/A
OCF growth 5YN/A